China Pharma Files Prospectus Supplement With The U.S. SEC Under Which The Company May Offer And Sell From Time To Time Shares Of Common Stock, With An Aggregate Offering Price Of Up To $600,000
China Pharma Files Prospectus Supplement With The U.S. SEC Under Which The Company May Offer And Sell From Time To Time Shares Of Common Stock, With An Aggregate Offering Price Of Up To $600,000
惠普森医药向美国证券交易委员会提交了补充招股说明书，根据该说明书，公司可能会不时发行和卖出普通股，累计发行价格可达60万美元。
China Pharma Holdings, Inc. (NYSE:CPHI) ("China Pharma," or the "Company"), a specialty pharmaceutical company, today announced that it has filed a prospectus supplement with the U.S. Securities and Exchange Commission (the "SEC") under which the Company may offer and sell from time to time shares of common stock, par value $0.001 per share (the "Common Stock"), with an aggregate offering price of up to $600,000 (the "Financing").
惠普森医药控股公司（纽交所：CPHI）（"惠普森医药"或"公司"），是一家专业药品公司，今日宣布已向美国证券交易委员会（"SEC"）提交了一份招股说明书补充文件，根据该文件，公司可能不时提供和出售普通股，面值为每股0.001美元（"普通股"），总发行价格高达600,000美元（"融资"）。
资讯热榜
更新时间